Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Modern Pathology

• Publication date

  2005-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/modpathol.3800431PMID 15861213
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preoperative prediction of Gleason grade in radical prostatectomy specimens: the influence of different Gleason grades from multiple positive biopsy sites

  2005cited by this paper
• Closest Distance Between Tumor and Resection Margin in Radical Prostatectomy Specimens: Lack of Prognostic Significance

  2005cited by this paper
• Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.

  2005cited by this paper
• Cancer Statistics, 2005

  2005cited by this paper
• The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy.

  2005cited by this paper
• Natural history of early, localized prostate cancer.

  2004cited by this paper
• Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma

  2004cited by this paper
• Natural history of early localized prostate cancer.

  2004cited by this paper
• Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative prediction.

  2003cited by this paper
• Predicting tumor volume in radical prostatectomy specimens from patients with prostate cancer.

  2003cited by this paper
• Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.

  2001cited by this paper
• Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors?

  2001cited by this paper
• Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy.

  2000cited by this paper
• The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system.

  2000cited by this paper
• Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen.

  1999cited by this paper
• Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia.

  1999cited by this paper
• Biological determinants of cancer progression in men with prostate cancer.

  1999cited by this paper
• Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings.

  1998cited by this paper
• Independent origin of multiple foci of prostatic intraepithelial neoplasia

  1998cited by this paper
• Evidence of independent origin of multiple tumors from patients with prostate cancer.

  1998cited by this paper
• Cancer volume of lymph node metastasis predicts progression in prostate cancer.

  1998cited by this paper
• Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens--a different view.

  1997cited by this paper
• The definition and preoperative prediction of clinically insignificant prostate cancer.

  1996cited by this paper
• The definition and preoperative prediction of clinically insignificant prostate cancer.

  1996cited by this paper
• Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies.

  1996cited by this paper
• Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

  1994cited by this paper
• Identification of insignificant prostate cancers: analysis of preoperative parameters.

  1994cited by this paper
• Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical implications.

  1994cited by this paper
• Linear regressive analysis using prostate‐specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer

  1993cited by this paper
• Staging of early prostate cancer: a proposed tumor volume-based prognostic index.

  1993cited by this paper
• Observations on the doubling time of prostate cancer. The use of serial prostate‐specific antigen in patients with untreated disease as a measure of increasing cancer volume

  1993cited by this paper
• Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

  1993cited by this paper
• Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens.

  1990cited by this paper
• Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma.

  1990cited by this paper
• Morphometric and clinical studies on 68 consecutive radical prostatectomies.

  1988cited by this paper
• Patterns of progression in prostate cancer.

  1986cited by this paper
• Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

  1974cited by this paper

• Oncological outcomes post focal low‐dose‐rate brachytherapy in low‐intermediate risk prostate cancer

  2026cites this paper
• MRI Pathway for Small Volume Prostate Gland Index Lesions; A Single Center Retrospective Analysis.

  2025cites this paper
• The Determinants of Toxicity in the Treatment of Prostate Cancer with a Focal, Intraprostatic "Microboost".

  2025cites this paper
• Differences in the pathogenetic characteristics of prostate cancer in the transitional and peripheral zones and the possible molecular biological mechanisms

  2023cites this paper
• Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected

  2023cites this paper
• Focal Boost in Prostate Cancer Radiotherapy: A Review of Planning Studies and Clinical Trials

  2023cites this paper
• Outcomes of partial gland ablation using high intensity focused ultrasound for prostate cancer.

  2022cites this paper
• Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future.

  2021cites this paper
• Machine Learning Methods for Histopathological Image Analysis: A Review

  2021cites this paper
• Do not underestimate anterior prostate cancer.

  2020cites this paper
• Zonal Anatomy of Prostate on MRI

  2020cites this paper
• Prostate MRI Essentials: A Practical Guide for Radiologists

  2020cites this paper
• Neoplasms of the Prostate

  2020cites this paper
• Analyzing the current practice patterns and views among urologists regarding focal therapy for prostate cancer.

  2019cites this paper
• The Prostate

  2019cites this paper
• Cribriform pattern and perineural invasion on MR/US fusion biopsy predict failure of selection criteria for prostatic hemigland ablation.

  2019cites this paper
• Combining high wavenumber and fingerprint Raman spectroscopy for the detection of prostate cancer during radical prostatectomy

  2018cites this paper
• Mesoscopic characterization of prostate cancer using Raman spectroscopy: potential for diagnostics and therapeutics

  2018cites this paper
• Molecular Pathology of High-Grade Prostatic Intraepithelial Neoplasia: Challenges and Opportunities.

  2018influential citation
• Computer Aided Detection of Prostate Cancer on Biparametric MRI Using a Quadratic Discriminant Model

  2017cites this paper
• Pathological Findings in Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy: Relation to Prostate Cancer Focal Therapy.

  2017cites this paper
• Identifying and Characterizing the Index Lesion

  2017cites this paper
• Incidence of intraductal carcinoma, multifocality and bilateral significant disease in radical prostatectomy specimens from Japan and United States

  2016cites this paper
• Prognosis of prostate cancer using color doppler ultrasonography

  2016cites this paper
• Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens

  2015cites this paper
• Precise preoperative localization of prostate cancer employing 12-core needle biopsy with a tissue-marking method for effective surgical strategy.

  2015cites this paper
• Tumor shrinkage associated with whole-mount histopathologic techniques in oral tongue carcinoma.

  2015cites this paper
• Significance of S 100 A 4 expression in prostatic adenocarcinoma

  2015cites this paper
• Pathological Features of Localized Prostate Cancer in China: A Contemporary Analysis of Radical Prostatectomy Specimens

  2015cites this paper
• Posterior subcapsular prostate cancer: identification with mpMRI and MRI/TRUS fusion-guided biopsy

  2015cites this paper
• Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.

  2015cites this paper
• Performance assessment of automated tissue characterization for prostate H and E stained histopathology

  2015cites this paper
• Gross tumor volume and clinical target volume in prostate cancer: How do satellites relate to the index lesion.

  2015cites this paper
• Multi-channel near-infrared spectroscopy imaging system for improvement of diagnostic accuracy in localized prostate cancer

  2014cites this paper
• Dynamic contrast-enhanced MR imaging features of the normal central zone of the prostate.

  2014cites this paper
• Pharmacokinetics of an injectable modified-release 2-hydroxyflutamide formulation in the human prostate gland using a semiphysiologically based biopharmaceutical model.

  2014cites this paper
• Re-evaluating the concept of “dominant/index tumor nodule” in multifocal prostate cancer

  2014influential citation
• Prostate Cancer: Optimal Tissue Processing for Diagnosis and Prognosis

  2014cites this paper
• Gleason Score 3 + 4=7 Prostate Cancer With Minimal Quantity of Gleason Pattern 4 on Needle Biopsy Is Associated With Low-risk Tumor in Radical Prostatectomy Specimen

  2014cites this paper
• Differences in prostate cancer grade, stage, and location in radical prostatectomy specimens from United States and Japan

  2014cites this paper
• Pathological Implications of Prostate Biopsy

  2013cites this paper
• MRI-Guided Biopsy for Prostate Cancer Detection: A Systematic Review of Current Clinical Results

  2013cites this paper
• Parameters predicting postoperative unilateral disease in patients with unilateral prostate cancer in diagnostic biopsy: a rationale for selecting hemiablative focal therapy candidates.

  2013cites this paper
• There is no role for focal therapy in prostate cancer.

  2013cites this paper
• The Pathology of Prostatic Carcinoma

  2013cites this paper
• Does prostate re-biopsy have to include a biopsy of the transitional zone?

  2013cites this paper
• Update on Diagnostic Criteria, on Biopsy and Surgical Specimen: Preinvasive Lesions, from Epithelial Cell Hyperplasia to Carcinoma In Situ and Invasive Carcinoma – First-Line Immuno-Phenotyping of Prostate Diseases

  2013cites this paper
• Selection Criteria for Focal Therapy of Prostate Cancer

  2013cites this paper
• UNIVERZITA PALACKÉHO V OLOMOUCI

  2013cites this paper
• Pathologic Basis for Focal Therapy: Understanding Cancer Grade, Volume, and Spatial Location

  2013cites this paper
• DOES PROSTATE RE-BIOPSY HAVE TO INCLUDE A BIOPSY OF THE TRANSITIONAL ZONE? JE NUTNá BIOPSIE TRANZICIONáLNí ZóNY PřI REBIOPSII PROSTATY?

  2013cites this paper
• Relation between prostate gland volume and some histological markers of malignancy

  2012cites this paper
• Focal Therapy, Differential Therapy, and Radiation Treatment for Prostate Cancer

  2012cites this paper
• [Relation between prostate gland volume and some histological markers of malignancy].

  2012cites this paper
• Anatomic, morphologic and genetic heterogeneity of prostate cancer: implications for clinical practice

  2012cites this paper
• Focal Therapy: Prostate Hemiablation as the First Historical Treatment Model for Focal Therapy of Early Stage Prostate Cancer

  2012cites this paper
• Management of prostate cancer.

  2012cites this paper
• Focal therapy for prostate cancer: patient selection and evaluation

  2012cites this paper
• Novel approaches to improve prostate cancer diagnosis and management in early‐stage disease

  2012cites this paper
• Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel

  2012cites this paper
• Optimum Prostate Biopsy: Techniques and Strategies

  2012cites this paper
• Staging of prostate cancer

  2012cites this paper
• Relación entre volumen de la glándula prostática y algunos marcadores histológicos de malignidad

  2012cites this paper
• Histological Trends and the Index Lesion in Localized Prostate Cancer

  2011cites this paper
• Molecular pathology of prostate cancer

  2011cites this paper
• Pathological characterization of unifocal prostate cancers in whole‐mount radical prostatectomy specimens

  2011cites this paper
• Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment

  2011cites this paper
• Kritische Bewertung der Vorhersagefähigkeit eines pathologisch unilateralen, organbegrenzten Prostatakarzinoms in einer "low- risk" Patientenkohorte

  2011cites this paper
• Tumor focality in prostate cancer: implications for focal therapy

  2011cites this paper
• True local recurrences do not metastasize

  2011cites this paper
• Focal Therapy is an Option for the Majority of Localised Prostate Cancers: A Histopathological Study of Contemporary UK Radical Prostatectomies

  2011cites this paper
• Comparative study of stromal metalloproteases expression in patients with benign hyperplasia and prostate cancer

  2011cites this paper
• Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?

  2011cites this paper
• Understanding the pathological features of focality, grade and tumour volume of early‐stage prostate cancer as a foundation for parenchyma‐sparing prostate cancer therapies: active surveillance and focal targeted therapy

  2011cites this paper
• Selection and mutation in the “new” genetics: an emerging hypothesis

  2010cites this paper
• Chapter 3 – The Pathology of Prostate Cancer

  2010cites this paper
• Fluorescence time-resolved imaging system embedded in an ultrasound prostate probe

  2010cites this paper
• Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low‐volume tumors

  2010cites this paper
• Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy.

  2010cites this paper
• Differential Gene Expression in Benign Prostate Epithelium of Men with and without Prostate Cancer: Evidence for a Prostate Cancer Field Effect

  2010cites this paper
• The impact of core biopsy fragmentation in prostate cancer

  2010cites this paper
• EVALUATION OF THE POTENTIAL OF DWI IN PROSTATE CANCER DETECTION

  2010cites this paper
• Impact of Prostate Cancer Multifocality on Its Biology and Treatment

  2010cites this paper
• Multifocal prostate cancer: biologic, prognostic, and therapeutic implications.

  2010cites this paper
• Salvage Cryotherapy: Is There a Role for Focal Therapy?

  2010cites this paper
• [Small volume (<0.5 cc) prostate cancer: characteristics and clinical implications].

  2009cites this paper
• Patient selection for hemiablative focal therapy of prostate cancer

  2009cites this paper
• Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trial.

  2009cites this paper
• Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort.

  2009cites this paper
• Pathologic basis of focal therapy for early-stage prostate cancer

  2009cites this paper
• A single institution experience with biochemical recurrence after radical prostatectomy for tumors that on pathology are of small volume or "insignificant".

  2009cites this paper
• Can contemporary transrectal prostate biopsy accurately select candidates for hemi‐ablative focal therapy of prostate cancer?

  2009cites this paper
• Small Volume (<0.5 cc) Prostate Cancer: Characteristics and Clinical Implications

  2009influential citation
• Focal Targeted Therapy Will Be a Future Treatment Modality for Early Stage Prostate Cancer

  2009cites this paper
• Laterality alone should not drive selection of candidates for hemi-ablative focal therapy.

  2009cites this paper
• Focal therapy for prostate cancer: pathologic basis

  2009cites this paper
• Pathology of prostate cancer and focal therapy ('male lumpectomy').

  2009cites this paper
• CHAPTER 32 – Prostate

  2009cites this paper
• Is the mammary gland an organ per se?

  2009cites this paper
• Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features.

  2008cites this paper